Answers are grounded in this paper and cite their sources.
Amyotrophic lateral sclerosis (ALS) remains a clinical diagnosis without validated biomarkers. To increase diagnostic sensitivity, an expert group modified the Airlie House diagnostic criteria and formulated new recommendations at a meeting on Awaji Island. Our retrospective analysis of patients referred over a 6-month period to the electromyography (EMG) laboratory for suspected motor neuron disease (MND) showed a higher agreement of the Awaji modifications than the Airlie House criteria with the clinical diagnosis of ALS.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: